Effects of Indralin on Immunohematological Parameters and DNA Damage in Irradiated ICR (CD-1) Outbred Mice


Цитировать

Полный текст

Открытый доступ Открытый доступ
Доступ закрыт Доступ предоставлен
Доступ закрыт Только для подписчиков

Аннотация

Abstract—Intragastric administration of radioprotector indralin (B-190 drug) to outbred SPF ICR (CD-1) mice 15 minutes before X-ray irradiation at doses of 6 Gy (LD-10/30), 6.5 Gy, and 7 Gy (LD-100/30) increases the 30-day survival of the animals and positively affects the state of the central organs of immunity and hematopoiesis, as well as the number of peripheral blood leukocytes. In addition, a positive effect on the behavioral reactions of the irradiated animals and striated muscles strength was noted. In addition to these secondary features of the indralin positive effect, a significant reduction of radiation-induced DNA damage in spleenocytes was observed using flow cytometry analysis of phosphorylated histone Н2АХ (γН2АХ) (1 h and eight days after X-ray irradiation) and DNA-comet assay (eight days after X-ray irradiation). The abovementioned methods are recommended for experiments investigating the influence of radioprotective drugs on DNA damage induction and repair in the irradiated organism, as well as for initial searching of potential radioprotectors and assessment of their effectiveness level in clinical practice and experiments.

Об авторах

A. Bushmanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

A. Osipov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Россия, Moscow; Moscow

M. Ignatov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

M. Vorontsova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

T. Karaulova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

A. Gordeev

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

E. Yashkina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

O. Nikitenko

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
Россия, Moscow; Moscow

T. Bychkova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences

Email: a1931192@mail.ru
Россия, Moscow; Moscow

N. Stavrakova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

I. Andrianova

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency

Email: a1931192@mail.ru
Россия, Moscow

T. Blokhina

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Россия, Moscow; Moscow

N. Vorobyeva

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Semenov Institute of Chemical Physics, Russian Academy of Sciences

Email: a1931192@mail.ru
Россия, Moscow; Moscow

A. Ivanov

State Research Center—Burnasyan Federal Medical Biophysical Center of Federal Medical Biological Agency; Federal State Budgetary Institution of Science “Russian Federation State Scientific Center—Institute of Biomedical Problems,” Russian Academy of Sciences; Joint Institute for Nuclear Research

Автор, ответственный за переписку.
Email: a1931192@mail.ru
Россия, Moscow; Moscow; Dubna


© Pleiades Publishing, Inc., 2019

Данный сайт использует cookie-файлы

Продолжая использовать наш сайт, вы даете согласие на обработку файлов cookie, которые обеспечивают правильную работу сайта.

О куки-файлах